ursodeoxycholic acid has been researched along with Varicose Veins in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jorgensen, R; Lindor, KD; Momah, N; Silveira, MG; Sinakos, E | 1 |
Barnes, DS; Bass, NM; Benner, KG; Bonacini, M; Boyer, JL; Boyer, TD; Carithers, RL; Combes, B; Contos, MJ; Di Bisceglie, AM; Emerson, SS; Flye, NL; Garcia-Tsao, G; Hofmann, AF; Kowdley, KV; Lake, JR; Lindsay, KL; Luketic, VA; Markin, RS; Martinez, EJ; Mayo, MJ; McCashland, TM; Mills, AS; Munoz, SJ; Peters, MG; Rosoff, L; Rubin, R; West, AB; Wheeler, DE; Zetterman, RK | 1 |
1 trial(s) available for ursodeoxycholic acid and Varicose Veins
Article | Year |
---|---|
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Cholagogues and Choleretics; Drug Therapy, Combination; Endoscopy; Female; Humans; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Prevalence; Survival Analysis; Treatment Failure; Ursodeoxycholic Acid; Varicose Veins | 2005 |
1 other study(ies) available for ursodeoxycholic acid and Varicose Veins
Article | Year |
---|---|
Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis.
Topics: Alkaline Phosphatase; Ascites; Bilirubin; Biomarkers; Cholagogues and Choleretics; Clinical Trials as Topic; Disease Progression; Endpoint Determination; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Multicenter Studies as Topic; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid; Varicose Veins | 2012 |